Skip to main content

  • STICH: CABG Survival Benefit Doesn't Hinge on Myocardial Viability

    • Posted: 08/21/2019
    • Author:

      Nicole Lou, Reporter, MedPage Today/CRTonline.org

    • 2019News Articles

    Is viability testing now unnecessary for CAD patients with low LVEF?

    Viable myocardium doesn't boost long-term benefit from coronary artery bypass grafting (CABG) in patients with ischemic cardiomyopathy and coronary artery disease (CAD), a STICH trial analysis found.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details